Video game therapy for lazy eye shows early promise, but trial cut short
NCT ID NCT07240311
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tested a computer-based therapy called AmblyoFix for treating lazy eye (amblyopia) in 40 people aged 8 to 19. Participants either used the therapy for 90 minutes daily or wore a standard eye patch. The study was stopped early, and only 4-week data is available, making it hard to draw firm conclusions. The goal was to see if the digital therapy works as well as patching and is easier for patients to stick with.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AmblyoFix binocular digital therapy (gamified visual tasks on a laptop with red-blue glasses)
What this could lead to
If it works, this could offer a more engaging alternative to eye patching for lazy eye, potentially improving adherence and visual outcomes.
What could go wrong
The trial was terminated early with only 40 participants and complete data only up to 4 weeks, so results are very limited. The therapy requires daily 90-minute sessions for 24 weeks, which may be hard to sustain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMBLYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nour Pajouhan Shargh Eye Specialist Clinic
Zahedan, Sistan & Balouchestan, Iran